Yao et al. proposed that miR-182-5p was the most prominently elevated miRNA in prostate cancer tissues as elucidated by RNA sequencing, and it accelerated tumor progression by mediating the ARRDC3/ITGB4 pathway [25]. This evidence concerns the gene ARRDC3 and prostate cancer.